SECsense Logo

Radiopharm Theranostics Limited's SEC Form 6-K: Securities Update & Compliance Report

$RADX
Form 6-K
Filed on: 2024-12-19
Source
Radiopharm Theranostics Limited's SEC Form 6-K: Securities Update & Compliance Report

Here are the key insights and information extracted from the provided section of the financial report for Radiopharm Theranostics Limited:

  1. Filing Type and Date:
  • This is a Form 6-K filed with the SEC.
  • The report is dated December 19, 2024.
  1. Company Information:
  • Name: Radiopharm Theranostics Limited
  • Address: Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
  • Commission File Number: 001-41621.
  1. Purpose of Filing:
  • The report serves as a notification to the SEC about the company's activities and announcements relevant to their securities.
  • Specifically, it includes an announcement made to the Australian Securities Exchange regarding the "Application for quotation of securities – RAD".
  1. Exhibit Information:
  • The announcement referred to in the report is attached as Exhibit 99.1, which contains the details of the application for quotation of their securities.
  1. Regulatory Compliance:
  • The report states that it shall not be deemed "filed" for purposes of the Securities Exchange Act and will not be incorporated into other filings under the Securities Act unless explicitly referred to.
  1. Signature:
  • The document is signed by Phillip Hains, the Company Secretary of Radiopharm Theranostics Limited, validating the content of the report.

This report highlights the company's ongoing efforts to list its securities and comply with international regulatory standards, specifically in relation to its operations in the U.S. market through the SEC. The filing of Form 6-K indicates that the company is maintaining transparency with investors regarding its activities.